Streetbeat News

Earnings

TIVC

Tivic Health Systems reported a year-over-year decrease in Q4 revenue, leading to a decline in its share price.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:27 pm

ASML

DE

SBRA

STLD

CNBC's 'Halftime Report Final Trades' featured recommendations for Deere & Company (DE), ASML Holding N.V. (ASML), Sabra Health Care REIT, Inc. (SBRA), and Steel Dynamics, Inc. (STLD). Key updates include leadership changes at Deere, ASML's share buyback transactions, Sabra's strong Q4 sales, and Steel Dynamics' positive Q1 earnings guidance.

Portfolio Pulse from Avi Kapoor

March 26, 2024 | 12:25 pm

BLUE

Bluebird Bio's stock is trading lower following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:24 pm

DELL

PTF

SRHQ

Dell Technologies Inc (NYSE:DELL) has reduced its workforce as part of a cost-cutting strategy, facing a decline in PC demand and revenue. Despite a 12% revenue drop in its PC division, Dell anticipates growth in this segment for the year. The company also expects challenges from rising input costs and changes in its VMware relationship. Other tech giants like Alphabet, Meta, Microsoft, and Amazon have also announced significant layoffs. Dell's stock has risen 198% in the last 12 months, with exposure through SRHQ and PTF ETFs. DELL shares increased by 1.33% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

March 26, 2024 | 12:24 pm

AMZN

CART

TTD

WOR

Insiders at Amazon.com, The Trade Desk, Worthington Enterprises, and Maplebear have recently sold shares. These sales could indicate various sentiments about the companies' future prospects or stock valuations. Notably, each company has had recent developments, such as earnings reports, analyst reiterations, or price target adjustments, which could influence investor perceptions and stock performance.

Portfolio Pulse from Avi Kapoor

March 26, 2024 | 12:22 pm

THRD

Third Harmonic Bio reported a FY23 EPS of $(0.78), an improvement from $(2.45) YoY. The company's cash position is strong at $269.1 million, expected to support operations through 2026. R&D expenses decreased slightly, while G&A expenses rose due to the costs of being a public company. The net loss for the year narrowed to $30.8 million from $35.2 million.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:20 pm

FRZA

Forza X1 (FRZA) reported a 2023 loss per share of $(0.44). The company's cash, cash equivalents, and marketable securities stood at approximately $12.80 million at the end of 2023, slightly up from $12.767 million at the end of 2022.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:17 pm

STRO

Sutro Biopharma's stock price increased following the announcement of its financial results for the fiscal year 2023.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:16 pm

THRD

Third Harmonic Bio reported a Q4 net loss of $6.8 million, but maintains a strong cash balance of $269.1 million, indicating financial stability despite the loss.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:14 pm

TNON

Tenon Medical, Inc. (NASDAQ:TNON) announced significant progress in a post-market study of its Catamaran SI Joint Fusion System for treating sacroiliac joint disorders. Preliminary results at 12-month follow-up show 100% fusion response, marked improvements in pain scores, disability, and high patient satisfaction. Study enrollment is expected to complete soon, with patients evaluated up to 24 months.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:11 pm